Table 2 Characteristics of the study sample at each wave.

From: Cerebral small vessel disease burden and longitudinal cognitive decline from age 73 to 82: the Lothian Birth Cohort 1936

 

n

Wave 2 (n = 540)

n

Wave 3 (n = 463)

n

Wave 4 (n = 372)

n

Wave 5 (n = 300)

Sociodemographic

 Age, years

540

72.5 (0.5)

463

76.2 (0.7)

372

79.5 (0.6)

300

82.0 (0.5)

 Female, n (%)

540

252 (46.7%)

463

217 (46.9%)

372

195 (52.4%)

300

147 (49.0%)

 Education, years

540

10.9 (1.2)

463

10.9 (1.2)

372

10.9 (1.2)

300

11.0 (1.2)

Vascular risk

 Hypertension history, n (%)

540

259 (48.0%)

462

251 (54.3%)

372

218 (58.6%)

300

176 (58.7%)

 Systolic blood pressure, mmHg

534

146.5 (18.0)

458

147.4 (18.5)

366

144.2 (17.9)

294

147.2 (20.2)

 Diastolic blood pressure, mmHg

534

79.7 (18.0)

458

80.3 (9.8)

366

78.2 (9.7)

294

78.6 (10.5)

 Diabetes history, n (%)

540

54 (10.0%)

463

52 (11.2%)

371

42 (11.3%)

300

33 (11.0%)

 HbA1c mmol/mol

518

39.0 (6.4)

438

40.8 (7.1)

348

40.4 (8.0)

280

40.2 (8.0)

 Cholesterol, mmol/l

521

5.2 (1.1)

426

5.0 (1.2)

360

5.0 (1.2)

284

4.9 (1.2)

 Cardiovascular disease history, n (%)

540

154 (28.5%)

463

152 (32.8%)

372

135 (36.3%)

298

118 (39.6)

 Smoking status, n (%)

540

Ever = 274 (50.7%); Never = 266 (49.3%)

462

Ever = 218 (47.2%); Never = 244 (52.8%)

372

Ever = 204 (54.8%); Never = 168 (45.2%)

300

Ever = 167 (55.7%); Never = 133 (44.3%)

Cognitive

 Moray House Test age-11 (raw score, max 76)

511

50.2 (11.9)

437

50.9 (11.6)

372

51.1 (11.7)

283

51.2 (11.5)

Neuroimaging

 WMH volume cm3

537

12.2 (12.8)

387

16.4 (15.3)

309

20.5 (17.7)

241

22.4 (18.8)

 Total brain volume cm3

533

993.7 (88.4)

387

976.4 (88.5)

309

965.4 (87.0)

241

947.3 (85.5)

 PVS count

540

258.7 (94.6)

      

 Lacunes, n (%)

540

Present = 28 (5.1%); Absent = 512 (94.9%)

      

 Microbleeds, n (%)

540

Present = 65 (12.0%); Absent = 475 (88.0%)

      
  1. Values are mean (SD) unless otherwise specified.
  2. PVS visible perivascular spaces, WMH white matter hyperintensities of presumed vascular origin.